West Pharmaceutical Services (WST) Revenue (2016 - 2025)
Historic Revenue for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $805.0 million.
- West Pharmaceutical Services' Revenue rose 750.53% to $805.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.1 billion, marking a year-over-year increase of 625.26%. This contributed to the annual value of $3.1 billion for FY2025, which is 625.26% up from last year.
- West Pharmaceutical Services' Revenue amounted to $805.0 million in Q4 2025, which was up 750.53% from $804.6 million recorded in Q3 2025.
- Over the past 5 years, West Pharmaceutical Services' Revenue peaked at $805.0 million during Q4 2025, and registered a low of $670.7 million during Q1 2021.
- Moreover, its 5-year median value for Revenue was $727.2 million (2021), whereas its average is $731.8 million.
- As far as peak fluctuations go, West Pharmaceutical Services' Revenue soared by 3725.34% in 2021, and later crashed by 685.86% in 2024.
- West Pharmaceutical Services' Revenue (Quarter) stood at $730.8 million in 2021, then fell by 3.02% to $708.7 million in 2022, then grew by 3.29% to $732.0 million in 2023, then rose by 2.3% to $748.8 million in 2024, then grew by 7.51% to $805.0 million in 2025.
- Its Revenue was $805.0 million in Q4 2025, compared to $804.6 million in Q3 2025 and $766.5 million in Q2 2025.